Gensini评分与冠状动脉粥样硬化性心脏病合并非酒精性脂肪性肝病的相关性研究

摘要/Abstract

摘要： 目的分析Gensini评分与冠状动脉粥样硬化性心脏病(CAD)患者合并非酒精性脂肪性肝病(NAFLD)的相关性。方法收集2018年1月—2021年12月期间梅州市人民医院收治的CAD患者340例,其中男性252例,女性88例,平均年龄(58.3±9.2)岁;将患者分为CAD合并NAFLD(NAFLD组)164例与单纯CAD(非NAFLD组)176例,比较两组资料,分析NAFLD组肝组织学特征Gensini评分结果。结果 NAFLD组年龄为(57.4±9.6)岁,显著小于非NAFLD组患者[(59.0±9.1)岁,P<0.05];NAFLD组BMI为(27.2±3.1)kg/m²,显著高于非NAFLD组[(24.8±3.4)kg/m²,P<0.05];NAFLD组腰围为(96.5±9.1)cm,显著高于非NAFLD组[(84.6±9.5)cm,P<0.05];NALFD组HDL、TG为(0.9±0.2)mmol/L、(1.8±0.5)mmol/L,与非NAFLD组[(1.1±0.2)mmol/L、(1.6±0.4)mmol/L]比,差异具有统计学意义(P<0.05);此外,NAFLD组Gensini评分为(56.9±9.1)分,显著高于非NAFLD组[(48.2±8.2)分,P<0.05]。记录收集NAFLD组冠脉病变程度轻、中及重度分别为32例(19.5%)、21例(12.8%)及111例(67.7%),非NAFLD为55例(31.2%)、38例(21.6%)及83例(47.1%),差异具有统计学意义(P<0.05)。另外164例CAD合并NAFLD患者肝脂肪变程度S0级20例,S1级57例,S2级64例,S3级23例,各肝脂肪变程度Gensini评分分别为(10.5±1.3)分、(34.4±4.2)分、(65.9±8.0)分及(130.8±15.7)分,差异具有统计学意义(P<0.05)。结论不同肝脂肪变程度CAD合并NAFLD患者Gensini评分具有显著差异,Gensini评分有助于定量评价患者的肝脂肪变程度。

关键词: 冠状动脉粥样硬化性心脏病, 非酒精性脂肪性肝病, Gensini评分

Abstract: Objective To explore the relationship between nonalcoholic fatty liver disease (NAFLD) and Gensini score in patients with coronary atherosclerotic disease (CAD).Methods 340 CAD patients hospitalized from January 2018 to December 2021 were collected, including 252 males and 88 females in Meizhou People’s Hospital, with an average age of (58.3 ± 9.2) years. 340 CAD patients were divided into 164 cases of CAD combined with NAFLD (NAFLD group) and 176 cases of simple CAD (non-NAFLD group). The diagnosis of CAD and NAFLD met the requirements. The clinical data of NAFLD group and non-NAFLD group were compared, and the results of Gensini score of liver histological features in NAFLD group were analyzed.Results The age, body mass index (BMI) of NAFLD group were (57.4 ± 9.6) years old, (24.8 ± 3.4) kg/m², which were significantly different with non-NAFLD group [(59.0 ± 9.1) years old, (27.2 ± 3.1) kg/m², P<0.05]. The waist circumference of NAFLD group was (96.5 ± 9.1)cm, which was significantly higher than that of non-NAFLD group [(84.6 ± 9.5) cm, P<0.05]. High-density lipoprotein (HDL) and triglyceride (TG) in NALFD group were (0.9 ± 0.2) mmol/l and (1.8±0.5) mmol/l, which were significantly different from those in non-NAFLD group [(1.1 ± 0.2) mmol/l and (1.6 ± 0.4) mmol/l] (P<0.05). In addition, Gensini score of NAFLD group was (56.9 ± 9.1) points, significantly higher than that of non-NAFLD group [(48.2 ± 8.2) points, P<0.05]. The mild, moderate and severe degree of coronary artery lesions in NAFLD group were 32 cases (19.5%), 21 cases (12.8%) and 111 cases (67.7%), while those in non-NAFLD group were 55 cases (31.2%), 38 cases (21.6%) and 83 cases (47.1%), the difference was statistically significant. In 64 CAD patients with NAFLD, the degree of hepatic steatosis was 20 cases in S0 grade, 57 cases in S1 grade, 64 cases in S2 grade and 23 cases in S3 grade. Gensini scores of each degree of hepatic steatosis were (10.5 ± 1.3) points, (34.4 ± 4.2) points, (65.9 ± 8.0) points and (130.8 ± 15.7) points, respectively.Conclusion Gensini scores of patients with CAD and NAFLD of different degrees of liver steatosis are significantly different, and Gensini scores are helpful to quantitatively evaluate the degree of liver steatosis of patients.

Key words: Coronary atherosclerotic heart disease, Nonalcoholic fatty liver disease, Gensini score

张奇峰, 苗雷明, 钟方明, 何雪波, 黄俊平. Gensini评分与冠状动脉粥样硬化性心脏病合并非酒精性脂肪性肝病的相关性研究[J]. 肝脏, 2022, 27(12): 1314-1317.

ZHANG Qi-feng, MIAO lei-ming, ZHONG Fang-ming, HE Xue-bo, HUANG Jun-ping. Correlational research of Gensini score and coronary atherosclerotic disease complicated with nonalcoholic fatty liver disease[J]. Chinese Hepatolgy, 2022, 27(12): 1314-1317.

参考文献

[1] Nafakhi H, Al-Mosawi A, Al-Nafakh H, et al. Association of pericardial fat volume with coronary atherosclerotic disease assessed by CT angiography. Br J Radiol, 2014, 87(1038):20130713.
[2] Hu X, Tong H. Dynamic and conventional electrocardiograms for diagnosing arrhythmic coronary atherosclerotic heart disease: a comparative analysis. Am J Transl Res, 2021, 13(5):5697-5701.
[3] Wong MC, Zhang DX, Wang HH. Rapid emergence of atherosclerosis in Asia: a systematic review of coronary atherosclerotic heart disease epidemiology and implications for prevention and control strategies. Curr Opin Lipido, 2015, 26(4):257-269.
[4] Zheng J, Huang M, Huang Q, et al. The relationship between fetuin-A and coronary atherosclerotic heart disease (CHD) and CHD-related risk factors: A retrospective study. Medicine (Baltimore), 2021, 100(43):e27481.
[5] Ades PA, Savage PD. Obesity in coronary heart disease: An unaddressed behavioral risk factor. Prev Med, 2017, 104:117-119.
[6] Shakiba M, Mansournia MA, Salari A, et al. Accounting for time-varying confounding in the relationship between obesity and coronary heart disease: analysis with G-estimation: The ARIC Study. Am J Epidemiol, 2018, 187(6):1319-1326.
[7] Chen LZ, Jing XB, Wu CF, et al. Nonalcoholic fatty liver disease-associated liver fibrosis is linked with the severity of coronary artery disease mediated by systemic inflammation. Dis Markers, 2021, 2021:6591784.
[8] Kopiczko N, Bobrus-Chociej A, Harasim-Symbor E, et al. Serum concentration of fatty acids in children with obesity and nonalcoholic fatty liver disease. Nutrition, 2021, 94:111541.
[9] Wang P, Qiang H, Song Y, et al. Association between nonalcoholic fatty liver and Gensini score in patients with coronary heart disease: a cross-sectional study. Cardiology, 2019, 144(3-4):90-96.
[10] 中华医学会肝病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病诊疗指南. 中华糖尿病杂志, 2010, 2(1): 15-19.
[11] Liao R, Fu YP, Wang T, et al. Metavir and FIB-4 scores are associated with patient prognosis after curative hepatectomy in hepatitis B virus-related hepatocellular carcinoma:a retrospective cohort study at two centers in China. Oncotarget, 2017, 8(1): 1774-1781.
[12] Targher G, Byrne CD, Tilg H. NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications. Gut, 2020, 69(9):1691-1705.
[13] Ballestri S, Lonardo A, Bonapace S, et al. Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease. World J Gastroenterol, 2014, 20(7):1724-1745.
[14] Peppes V, Rammos G, Manios E, et al. Correlation between myocardial enzyme serum levels and markers of inflammation with severity of coronary artery disease and Gensini score: a hospital-based, prospective study in Greek patients. Clin Interv Aging, 2008, 3(4):699-710.
[15] Cazzo E, Jimenez LS, Pareja JC, et al. Effect of Roux-en-Y gastric bypass on nonalcoholic fatty liver disease evaluated through NAFLD fibrosis score: a prospective study. Obes Surg, 2015, 25(6):982-985.